Medication Adherence and Its Influencing Factors among Patients with Heart Failure: A Cross Sectional Study

Mohamad Jarrah1, Yousef Khader2, Osama Alkouri3

  • 1Department of Internal Medicine, Jordan University of Science and Technology, P.O. Box 3030, Irbid 22110, Jordan.

PubMed

Insights

Medication adherence is a significant issue for heart failure patients in Jordan, with nearly half experiencing partial to poor adherence. Strategies targeting patient demographics like age and education are crucial for improving treatment outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacoeconomics

Background:

  • Heart failure (HF) is a chronic condition necessitating long-term medication regimens.
  • Global medication adherence rates for HF patients are suboptimal, with approximately 50% not adhering to prescribed treatments.
  • Understanding adherence barriers in specific populations, like Jordanians, is vital for targeted interventions.

Purpose of the Study:

  • To assess medication adherence levels among Jordanian patients diagnosed with heart failure.
  • To identify factors influencing medication adherence in this specific patient cohort.

Main Methods:

  • A cross-sectional study design was employed.
  • Data were collected from 164 heart failure patients attending cardiac clinics in northern Jordan.
  • The Medication Adherence Scale was utilized to quantify adherence levels.

Main Results:

  • Only 33.5% of patients demonstrated high medication adherence.
  • A substantial 47% exhibited partial to poor adherence to their prescribed heart failure medications.
  • Higher adherence rates were observed in younger patients (<60 years), those with higher education, married individuals, those living with others, and patients with health insurance.

Conclusions:

  • Patient-centered strategies focusing on age, education, marital status, and insurance are recommended to improve HF medication adherence in Jordan.
  • Developing and implementing feasible, context-specific strategies within Jordan's healthcare system is essential for enhancing patient adherence and health outcomes.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
17
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
121
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
471
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
394
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
430